Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Aiba

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drugK Hirata, N Horikoshi, K Aiba, et al.
International Journal of Clinical Oncology|November 29, 2001
Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancerY Ito, K Aiba, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 14, 1997
[Current status of low-dose CDDP. 5-FU therapy for solid malignant tumors--nationwide questionnaire survey]S Saji, K Aiba, H Araki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2000
[Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development]H Akaza, K Aiba, S Isonishi, et al.
Hepato-Gastroenterology|June 17, 1999
Intrahepatic interleukin-2 with chemotherapy for unresectable liver metastases: a randomized multicenter trialK Okuno, M Yasutomi, M Kon, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2001
[Comparison of management of advanced cancer in various organs]H Akaza, T Saeki, K Kawai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 2001
[Platinum compounds in cancer therapy--past, present, and future]H Akaza, N Saijo, K Aiba, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 5, 1998
[Phase I study of raltitrexed (ZD-1694)]N Horikoshi, K Aiba, M Fukuoka, et al.
ESMO Open|March 14, 2021
S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the phase III ACTS-CC 02 trialJ Watanabe, S Sasaki, T Kusumoto, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drugK Hirata, N Horikoshi, K Aiba, et al.
International Journal of Clinical Oncology|November 29, 2001
Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancerY Ito, K Aiba, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 14, 1997
[Current status of low-dose CDDP. 5-FU therapy for solid malignant tumors--nationwide questionnaire survey]S Saji, K Aiba, H Araki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2000
[Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development]H Akaza, K Aiba, S Isonishi, et al.
Hepato-Gastroenterology|June 17, 1999
Intrahepatic interleukin-2 with chemotherapy for unresectable liver metastases: a randomized multicenter trialK Okuno, M Yasutomi, M Kon, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2001
[Comparison of management of advanced cancer in various organs]H Akaza, T Saeki, K Kawai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 2001
[Platinum compounds in cancer therapy--past, present, and future]H Akaza, N Saijo, K Aiba, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 5, 1998
[Phase I study of raltitrexed (ZD-1694)]N Horikoshi, K Aiba, M Fukuoka, et al.
ESMO Open|March 14, 2021
S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the phase III ACTS-CC 02 trialJ Watanabe, S Sasaki, T Kusumoto, et al.
Pageof 7